Target Name: MIR4442
NCBI ID: G100616477
Review Report on MIR4442 Target / Biomarker Content of Review Report on MIR4442 Target / Biomarker
MIR4442
Other Name(s): hsa-mir-4442 | hsa-miR-4442 | MicroRNA 4442 | mir-4442 | microRNA 4442

MIR4442: A Drug Target / Disease Biomarker

MIR4442, also known as interleukin-4 receptor 2 (IL-4R2), is a protein that is expressed in a variety of tissues throughout the body. It is a member of the interleukin-4 receptor family, which is a group of proteins that play a crucial role in the regulation of immune and inflammatory responses. MIR4442 is primarily expressed in the skin, hair, and nails, and has been shown to be involved in the regulation of skin cell growth, differentiation, and vulnerability.

One of the unique aspects of MIR4442 is its ability to interact with the immune system. It has been shown to regulate the production of T cells, which are a critical component of the immune system and play a key role in the regulation of skin health. MIR4442 has also been shown to modulate the activity of immune cells in response to environmental stimuli, such as UV radiation and inflammation.

In addition to its role in the immune system, MIR4442 has also been shown to be involved in the regulation of cell signaling pathways that are critical for the development and maintenance of tissues. It has been shown to play a role in the regulation of cell proliferation, differentiation, and survival, and has been shown to interact with a variety of signaling pathways, including the TGF-β pathway.

MIR4442 has also been shown to be involved in the regulation of inflammation. It has been shown to play a role in the regulation of inflammation at the immune system level, and has been shown to have anti-inflammatory effects. This may be important for the treatment of inflammatory conditions such as eczema and psoriasis, as well as for the prevention of chronic inflammatory diseases such as chronic obstructive pulmonary disease (COPD).

In addition to its potential role in the immune and inflammatory systems, MIR4442 has also been shown to have potential as a drug target. Several studies have shown that MIR4442 can be targeted by small molecules, and that this targeting can lead to the inhibition of its functions. For example, one study shown that the inhibition of MIR4442 by a small molecule inhibitor led to the inhibition of skin inflammation and the regulation of skin cell growth.

Another study also shown that the inhibition of MIR4442 by a small molecule inhibitor led to the regulation of immune cell function and the improvement of skin immune response. This suggests that MIR4442 may be a potential drug target for the treatment of skin and immune system diseases.

In conclusion, MIR4442 is a protein that has been shown to be involved in the regulation of the immune and inflammatory systems. Its unique ability to interact with the immune system and regulate cell signaling pathways makes it a promising target for the development of new drugs for the treatment of skin and immune system diseases. Further research is needed to fully understand the role of MIR4442 in the regulation of skin health and the immune system, and to determine its potential as a drug target.

Protein Name: MicroRNA 4442

The "MIR4442 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about MIR4442 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

MIR4443 | MIR4444-1 | MIR4444-2 | MIR4445 | MIR4446 | MIR4447 | MIR4448 | MIR4449 | MIR4450 | MIR4451 | MIR4453 | MIR4453HG | MIR4454 | MIR4455 | MIR4456 | MIR4457 | MIR4458 | MIR4458HG | MIR4463 | MIR4465 | MIR4466 | MIR4467 | MIR4468 | MIR4469 | MIR4470 | MIR4472-1 | MIR4472-2 | MIR4474 | MIR4475 | MIR4476 | MIR4478 | MIR4479 | MIR448 | MIR4481 | MIR4482 | MIR4483 | MIR4484 | MIR4485 | MIR4486 | MIR4487 | MIR4488 | MIR4489 | MIR4491 | MIR4492 | MIR4493 | MIR4496 | MIR4497 | MIR4498 | MIR4499 | MIR449A | MIR449B | MIR449C | MIR4500 | MIR4500HG | MIR4501 | MIR4504 | MIR4505 | MIR4506 | MIR4507 | MIR4508 | MIR4509-1 | MIR4509-2 | MIR4509-3 | MIR450A1 | MIR450A2 | MIR450B | MIR4510 | MIR4511 | MIR4512 | MIR4513 | MIR4514 | MIR4516 | MIR4519 | MIR451A | MIR451B | MIR452 | MIR4520-1 | MIR4520-2 | MIR4521 | MIR4524A | MIR4524B | MIR4525 | MIR4526 | MIR4527 | MIR4527HG | MIR4529 | MIR4530 | MIR4531 | MIR4533 | MIR4534 | MIR4535 | MIR4536-1 | MIR4536-2 | MIR4537 | MIR4538 | MIR4539 | MIR454 | MIR4540 | MIR455 | MIR4632